Virulence of Bacillus anthracis, the causative agent of anthrax, is associated with the activities of its secreted toxin. Anthrax toxin is comprised of a single cell-binding moiety, protective antigen (PA), and two catalytic moieties, lethal factor (LF) and edema factor (EF). LF is a protease that cleaves members of the MAP kinase kinase family of signaling proteins, and causes lysis of macrophages. EF is an adenylate cyclase that increases cellular levels of cAMP, disrupting water homeostasis and neutrophil function. PA binds the host cellular anthrax toxin receptor (ATR) and subsequently binds and translocates LF and EF into the host cytosol where they are active. Thus, the ability of anthrax toxin to exert its toxic effects on mammalian cells depends on the ability of PA to bind ATR. Very little is known about the natural function of ATR, and no natural ligands for this receptor have been reported. However, PA binds ATR through a structurally conserved integrin-like inserted (I) domain. I domains function as protein-protein interaction modules, and thus it is likely that host proteins that normally interact with ATR do so via the same domain to which PA binds. Identifying the non-toxin interactions that ATR is capable of engaging in and defining the binding requirements for both toxin and natural ligands will provide valuable information for the development of antitoxins that block toxin-receptor interaction while leaving normal ATR interactions intact. Therefore, the primary goal of these proposed studies is to elucidate the molecular requirements for binding to ATR. ATR ligands will be identified and ATR-PA and ATR-ligand interactions will be characterized. Comparative analysis between toxin and ligand interactions will be used to determine if the requirements for binding overlap or are distinct. Additionally phage display libraries will be screened for peptides that bind specifically to ATR. The information learned from these studies wilt be used to develop distinct classes of antitoxins based on soluble receptor, toxin or ligand mimetics, or small peptides that specifically block PA-ATR interactions. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI057870-03
Application #
6986201
Study Section
Special Emphasis Panel (ZRG1-BM-1 (02))
Program Officer
Breen, Joseph J
Project Start
2003-12-15
Project End
2008-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
3
Fiscal Year
2006
Total Cost
$335,354
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Gillespie, Eugene J; Ho, Chi-Lee C; Balaji, Kavitha et al. (2013) Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proc Natl Acad Sci U S A 110:E4904-12
Larabee, Jason L; Maldonado-Arocho, Francisco J; Pacheco, Sergio et al. (2011) Glycogen synthase kinase 3 activation is important for anthrax edema toxin-induced dendritic cell maturation and anthrax toxin receptor 2 expression in macrophages. Infect Immun 79:3302-8
Ramey, Jordan D; Villareal, Valerie A; Ng, Charles et al. (2010) Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding. Biochemistry 49:7403-10
Maldonado-Arocho, Francisco J; Bradley, Kenneth A (2009) Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3beta. Infect Immun 77:2036-42
Averette, Kathleen M; Pratt, Matthew R; Yang, Yanan et al. (2009) Anthrax lethal toxin induced lysosomal membrane permeabilization and cytosolic cathepsin release is Nlrp1b/Nalp1b-dependent. PLoS One 4:e7913
Cote, Christopher K; DiMezzo, Tracy L; Banks, David J et al. (2008) Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. Microbes Infect 10:613-9
Sanchez, Ana M; Thomas, Diane; Gillespie, Eugene J et al. (2007) Amiodarone and bepridil inhibit anthrax toxin entry into host cells. Antimicrob Agents Chemother 51:2403-11
Banks, David J; Bradley, Kenneth A (2007) SILENCE: a new forward genetic technology. Nat Methods 4:51-3
Maldonado-Arocho, Francisco J; Fulcher, Jennifer A; Lee, Benhur et al. (2006) Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol Microbiol 61:324-37
Christman, Karen L; Requa, Michael V; Enriquez-Rios, Vanessa D et al. (2006) Submicron streptavidin patterns for protein assembly. Langmuir 22:7444-50

Showing the most recent 10 out of 14 publications